Compile Data Set for Download or QSAR
Report error Found 42 Enz. Inhib. hit(s) with all data for entry = 50011396
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106090((S)-3-(3,4-Dimethoxy-phenyl)-3-[2-((4-methoxy-buty...)
Affinity DataIC50: 1.30nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106091((S)-3-Benzo[1,3]dioxol-5-yl-3-((S)-4-methyl-2-{2-[...)
Affinity DataIC50: 3nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106083((S)-3-(4-Methoxy-phenyl)-3-[2-((3-methoxy-propyl)-...)
Affinity DataIC50: 4.70nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106086((S)-3-(3,4-Dimethoxy-phenyl)-3-[2-((3-methoxy-prop...)
Affinity DataIC50: 7.10nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106085((E)-(S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-...)
Affinity DataIC50: 7.70nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by mouse Very late antigen 4 (VLA-4) integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106085((E)-(S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-...)
Affinity DataIC50: 7.90nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to fibronectin by Very late antigen 4 (VLA-4)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106082((S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-urei...)
Affinity DataIC50: 12nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106086((S)-3-(3,4-Dimethoxy-phenyl)-3-[2-((3-methoxy-prop...)
Affinity DataIC50: 13nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to fibronectin by Very late antigen 4 (VLA-4)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106082((S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-urei...)
Affinity DataIC50: 14nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to fibronectin by Very late antigen 4 (VLA-4)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106085((E)-(S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-...)
Affinity DataIC50: 15nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106098((R)-3-((S)-4-Methyl-2-{2-[4-(3-o-tolyl-ureido)-phe...)
Affinity DataIC50: 17nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106093((S)-3-(3,4-Dimethoxy-phenyl)-3-[2-((3-methyl-butyl...)
Affinity DataIC50: 20nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106085((E)-(S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-...)
Affinity DataIC50: 21nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by rat Very late antigen 4 (VLA-4) integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106086((S)-3-(3,4-Dimethoxy-phenyl)-3-[2-((3-methoxy-prop...)
Affinity DataIC50: 22nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by rat Very late antigen 4 (VLA-4) integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106082((S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-urei...)
Affinity DataIC50: 22nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by mouse Very late antigen 4 (VLA-4) integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106082((S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-urei...)
Affinity DataIC50: 25nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by rat Very late antigen 4 (VLA-4) integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106086((S)-3-(3,4-Dimethoxy-phenyl)-3-[2-((3-methoxy-prop...)
Affinity DataIC50: 27nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by mouse Very late antigen 4 (VLA-4) integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106083((S)-3-(4-Methoxy-phenyl)-3-[2-((3-methoxy-propyl)-...)
Affinity DataIC50: 27nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by rat Very late antigen 4 (VLA-4) integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106099(Lithium; (S)-3-[2-((3-methyl-butyl)-{2-[4-(3-o-tol...)
Affinity DataIC50: 29nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106083((S)-3-(4-Methoxy-phenyl)-3-[2-((3-methoxy-propyl)-...)
Affinity DataIC50: 36nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to fibronectin by Very late antigen 4 (VLA-4)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106102((E)-(S)-3-[2-((3-Methyl-butyl)-{2-[4-(3-o-tolyl-ur...)
Affinity DataIC50: 45nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106083((S)-3-(4-Methoxy-phenyl)-3-[2-((3-methoxy-propyl)-...)
Affinity DataIC50: 52nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by mouse Very late antigen 4 (VLA-4) integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106097(3-{[2-((3-Methyl-butyl)-{2-[4-(3-o-tolyl-ureido)-p...)
Affinity DataIC50: 98nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106087(1,3-Diphenyl-urea derivative | CHEMBL98307)
Affinity DataIC50: 2.90E+3nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106094(1,3-Diphenyl-urea derivative | CHEMBL98793)
Affinity DataIC50: 5.90E+3nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-7(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106083((S)-3-(4-Methoxy-phenyl)-3-[2-((3-methoxy-propyl)-...)
Affinity DataIC50: 6.14E+3nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by alpha4-beta7 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106088(Lithium; (R)-((S)-5-methyl-3-{2-[4-(3-o-tolyl-urei...)
Affinity DataIC50: 6.40E+3nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106095((S)-3-((S)-5-Methyl-3-{2-[4-(3-o-tolyl-ureido)-phe...)
Affinity DataIC50: 7.30E+3nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106084([N-Allyl-N'-((R)-4-methyl-2-{2-[4-(3-o-tolyl-ureid...)
Affinity DataIC50: 1.10E+4nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106096(3-[((R)-4-Methyl-2-{2-[4-(3-o-tolyl-ureido)-phenyl...)
Affinity DataIC50: 3.70E+4nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106089((S)-3-(4-Methoxy-phenyl)-3-[2-((3-methoxy-propyl)-...)
Affinity DataIC50: 7.50E+4nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-7(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106085((E)-(S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by alpha4-beta7 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-7(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106086((S)-3-(3,4-Dimethoxy-phenyl)-3-[2-((3-methoxy-prop...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by alpha4-beta7 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-7(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106082((S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-urei...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to VCAM-1 by alpha4-beta7 integrinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106103((E)-(R)-3-((R)-5-Methyl-3-{2-[4-(3-o-tolyl-ureido)...)
Affinity DataIC50: 1.03E+5nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106100([Benzyl-((S)-5-methyl-3-{2-[4-(3-o-tolyl-ureido)-p...)
Affinity DataIC50: 2.47E+5nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106092((S)-3-((R)-5-Methyl-3-{2-[4-(3-o-tolyl-ureido)-phe...)
Affinity DataIC50: 2.62E+5nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-4/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106101(1,3-Diphenyl-urea derivative | CHEMBL100886)
Affinity DataIC50: 5.00E+5nMAssay Description:In vitro Very late antigen 4 cell adhesion inhibitory activity measured by binding of fluorescently labeled Ramos cells to immobilized VCAM-1.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106082((S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-urei...)
Affinity DataIC50: 5.00E+5nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to fibronectin by Very late antigen 5 (VLA-5)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106085((E)-(S)-3-[2-((3-Methoxy-propyl)-{2-[4-(3-o-tolyl-...)
Affinity DataIC50: 5.00E+5nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to fibronectin by Very late antigen 5 (VLA-5)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106086((S)-3-(3,4-Dimethoxy-phenyl)-3-[2-((3-methoxy-prop...)
Affinity DataIC50: 5.00E+5nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to fibronectin by Very late antigen 5 (VLA-5)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Novartis Institute For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50106083((S)-3-(4-Methoxy-phenyl)-3-[2-((3-methoxy-propyl)-...)
Affinity DataIC50: 5.00E+5nMAssay Description:Inhibition of fluorescent Ramos cell adhesion to fibronectin by Very late antigen 5 (VLA-5)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed